临床试验用品市场规模、份额、成长分析（按阶段、按产品和服务、按最终用途、按治疗方法、按地区）－产业预测 2025-2032

临床试验用品市场规模预计在 2023 年达到 31 亿美元，并将从 2024 年的 33.1 亿美元成长到 2032 年的 56.5 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.9%。

受生物製药和医药领域研发成本上升、临床试验增加、新兴国家药物开发成本飙涨等因素影响，全球临床试验用品市场大幅成长。然而，由于药物研究高成本以及新冠疫情的持续影响，这种成长面临挑战。全球慢性病的流行进一步推动了该领域的需求。此外，契约製造製造商和服务供应商在提供外包解决方案方面至关重要，使製药公司能够改进药物配方并加强与同行的合作。已建立的物流和分销伙伴关係，例如 Fisher Clinical Services 和 Parexel International，也在推动市场发展，将临床试验用品定位为现代药物开发的基石。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析

临床试验用品市场规模（依阶段划分）及复合年增长率（2025-2032）

• 市场概览
• 第一阶段
• 第二阶段
• 第三阶段
• 其他的

临床试验用品市场规模（依产品及服务）及复合年增长率（2025-2032）

• 市场概览
• 製造业
• 储存和运输
• 供应链管理

临床试验用品市场规模（依最终用途和复合年增长率） (2025-2032)

• 市场概览
• 製药
• 生物製药
• 医疗设备
• 其他的

临床试验用品市场规模（依治疗方法划分）及复合年增长率（2025-2032）

• 市场概览
• 肿瘤学
• 中枢神经系统
• 心血管系统
• 感染疾病
• 代谢紊乱
• 其他的

临床试验用品市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Almac Group（UK）
• Thermo Fisher Scientific Inc.（USA）
• Marken（UPS）（USA）
• PCI Pharma Services（USA）
• Sharp Services LLC（USA）
• Cencora, Inc.（USA）
• Myonex（USA）
• Clinigen Limited（UK）
• Inceptua Group（Luxembourg）
• Eurofins Scientific（Luxembourg）
• IQVIA（USA）
• Parexel International Corporation（USA）
• ICON plc（Ireland）
• Catalent, Inc.（USA）
• Piramal Pharma Solutions（India）
• Biocair（UK）
• Lonza（Switzerland）
• World Courier（USA）
• Klifo A/S（Denmark）
• DHL Supply Chain（Germany）

结论和建议

Clinical Trial Supplies Market size was valued at USD 3.1 billion in 2023 and is poised to grow from USD 3.31 billion in 2024 to USD 5.65 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The global clinical trial supplies market is witnessing significant growth driven by rising R&D expenditures within biopharmaceutical and pharmaceutical sectors, an increase in clinical trials, and escalating drug development costs in developed nations. However, this growth faces challenges due to the high costs associated with drug research and the lingering effects of the COVID-19 pandemic. The increasing prevalence of chronic illnesses worldwide further fuels demand in this sector. Moreover, contract manufacturers and service providers are crucial in offering outsourcing solutions, allowing pharmaceutical companies to refine drug formulations and enhance collaboration with peers. Established logistics and distribution partnerships, such as with Fisher Clinical Services and PAREXEL International, are also boosting market expansion, positioning clinical trial supplies as a cornerstone of modern drug development.

Top-down and bottom-up approaches were used to estimate and validate the size of the Clinical Trial Supplies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Clinical Trial Supplies Market Segments Analysis

Global Clinical Trial Supplies Market is segmented by Phase, Products and Services, End Use, Therapeutic and region. Based on Phase, the market is segmented into Phase I, Phase II, Phase III and Others. Based on Products and Services, the market is segmented into Manufacturing, Storage and Distribution and Supply Chain Management. Based on End Use, the market is segmented into Pharmaceutical, Biologics, Medical device and Others. Based on Therapeutic, the market is segmented intooncology, CNS, Cardiovascular, Infectious disease, Metabolic disorders and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Clinical Trial Supplies Market

A significant driver of the global clinical trial supplies market is the growing emphasis on precision medicine. As therapies become more tailored to individual patients, there is an escalating demand for innovative treatment solutions and biologic medications. This shift necessitates the development of specialized clinical trial supplies to effectively manage the complexities associated with advanced clinical trial designs and the stratification of patients. Consequently, the evolution of precision medicine is propelling the need for refined and targeted clinical trial resources, ultimately shaping the landscape of clinical trials to better meet the diverse needs of patients and researchers alike.

Restraints in the Clinical Trial Supplies Market

The global clinical trial supplies market faces significant challenges due to disruptions in the global supply chain. Factors such as political conflicts, natural disasters, and health crises can severely impact the availability of essential materials and transportation logistics. These disruptions can lead to delays in the initiation of clinical trials and result in increased operational expenses, ultimately diminishing the overall efficiency of clinical research activities. The unpredictable nature of these events poses a substantial restraint, hindering progress and complicating the management of clinical trial supplies on a global scale.

Market Trends of the Clinical Trial Supplies Market

The Clinical Trial Supplies market is experiencing a significant shift towards decentralized clinical trials, driven by technological advancements and the growing acceptance of virtual study methodologies. This trend is enabling remote patient monitoring and broadening participant access, resulting in reduced operational costs and expedited trial timelines. By facilitating greater inclusivity and efficiency, decentralized trials are transforming traditional clinical research models, allowing for more dynamic patient engagement and data collection. As a result, pharmaceutical companies and CROs are increasingly investing in innovative supply chain solutions to adapt to these changes, positioning the market for continued growth and evolution through enhanced logistics and tailored supply strategies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global Clinical Trial Supplies Market Size by Phase & CAGR (2025-2032)

• Market Overview
• Phase I
• Phase II
• Phase III
• Others

Global Clinical Trial Supplies Market Size by Products and Services & CAGR (2025-2032)

• Market Overview
• Manufacturing
• Storage and Distribution
• Supply Chain Management

Global Clinical Trial Supplies Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Pharmaceutical
• Biologics
• Medical device
• Others

Global Clinical Trial Supplies Market Size by Therapeutic & CAGR (2025-2032)

• Market Overview
• Oncology
• CNS
• Cardiovascular
• Infectious disease
• Metabolic disorders
• Others

Global Clinical Trial Supplies Market Size & CAGR (2025-2032)

• North America (Phase, Products and Services, End Use, Therapeutic)
  • US
  • Canada
• Europe (Phase, Products and Services, End Use, Therapeutic)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Phase, Products and Services, End Use, Therapeutic)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Phase, Products and Services, End Use, Therapeutic)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Phase, Products and Services, End Use, Therapeutic)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Almac Group (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marken (UPS) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PCI Pharma Services (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sharp Services LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cencora, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myonex (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinigen Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inceptua Group (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IQVIA (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Catalent, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Pharma Solutions (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocair (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• World Courier (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Klifo A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DHL Supply Chain (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations